Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.42 |
| ▸ | CA1 | P00915 | 5/20 | 0.42 |
| ▸ | CA9 | Q16790 | 5/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.38 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13836564 | 0.96 | CA12 (0.42) | CA12CA1CA9CA2CA7 | |
| SCHEMBL2524244 | 0.87 | KAT6A (0.40) | CA12CA1CA9CA2CA7 | |
| SCHEMBL18614954 | 0.84 | MEN1 (0.36) | CA12CA1CA9CA2CA7 | |
| SCHEMBL3818350 | 0.84 | MAPT (0.47) | CA12CA1CA9CA2CA7 | |
| SCHEMBL4877310 | 0.83 | FFAR1 (0.43) | GAAALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL29549500 | 0.81 | MAOA (0.58) | MEN1KMT2AMAOAMAOBNPC1 | |
| SCHEMBL429910 | 0.81 | MAOA (0.58) | MEN1KMT2AMAOAMAOBNPC1 | |
| SCHEMBL2531150 | 0.79 | ALDH1A1 (0.45) | CA12CA1CA9CA2CA7 | |
| SCHEMBL268446 | 0.79 | CA12 (0.55) | CA12CA1CA9CA2CA7 | |
| SCHEMBL2850824 | 0.76 | ERN1 (0.45) | CA12CA1CA9CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130315989-A1 | METHOD FOR TREATING A PATIENT VIA PHOTODYNAMIC THERAPY COMPRISING A MACROMOLECULAR CAPSULE | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2013-11-28 | — | — | US | disclosed |
| US-20120045516-A1 | COMPOSITION FOR PHOTODYNAMIC THERAPY COMPRISING A MACROMOLECULAR CAPSULE | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2012-02-23 | — | — | US | disclosed |
| US-6974857-B1 | End-capped quinoxaline-containing hyperbranched aromatic poly(ether-ketones) | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2005-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130315989-A1 | METHOD FOR TREATING A PATIENT VIA PHOTODYNAMIC THERAPY COMPRISING A MACROMOLECULAR CAPSULE | TYR, CD47, PPOX | CA12 252/4885CA1 3669/4885CA9 181/4885 |
| US-20120045516-A1 | COMPOSITION FOR PHOTODYNAMIC THERAPY COMPRISING A MACROMOLECULAR CAPSULE | APC, TYR, CD47 | CA12 647/4885CA1 4076/4885CA9 584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.